Literature DB >> 9203928

Reporting of clinical trials in Gut: the CONSORT statement. Consolidated Standards of Reporting Trials.

M J Farthing, R G Newcombe.   

Abstract

Mesh：

Year:  1997        PMID： 9203928      PMCID： PMC1027152          DOI： 10.1136/gut.40.5.563

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

2.  How to report randomized controlled trials. The CONSORT statement.

Authors:  D Rennie
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

3.  Better reporting of randomised controlled trials: the CONSORT statement.

Authors:  D G Altman
Journal:  BMJ       Date:  1996-09-07

4.  Randomization by cluster. Sample size requirements and analysis.

Authors:  A Donner; N Birkett; C Buck
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897
  4 in total
  2 in total

1.  Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.

Authors:  M F Neurath; R Wanitschke; M Peters; F Krummenauer; K H Meyer zum Büschenfelde; J F Schlaak
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 2.  Better plans and more powerful evidence are needed in the research and treatment of chronic hepatitis B in China.

Authors:  Changtai Zhu; Yulu Gao; Lihui Jiang; Baoqiong Ding; Yongning Sun
Journal:  Int J Clin Exp Med       Date:  2015-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.